Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04767906
Title Cabozantinib Treatment in a Phase II Study for Patients With Hepatocellular Carcinoma (HCC) Refractory to PD-1 Inhibitors (CaPture)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Leipzig
Indications

hepatocellular carcinoma

Therapies

Cabozantinib

Age Groups: adult | senior
Covered Countries DEU


No variant requirements are available.